Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. RESULTS: Our findings revealed a stable number of patents and scientific articles published over the past five years. CONCLUSIONS: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

Guardado en:
Detalles Bibliográficos
Autores principales: Marques,Carine Santana Ferreira, Machado Júnior,Jorge Barreto, Andrade,Lucas Rannier de Melo, Andrade,Luciana Nalone, Santos,André Luis Souza dos, Cruz,Maria do Socorro Pires e, Chaud,Marco, Fricks,Alini Tinoco, Severino,Patrícia
Formato: Digital revista
Idioma:Portuguese
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2019
Acceso en línea:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100636
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!